Scientific Advisory Board
The governance of HudsonAlpha is carried out through the actions of two boards, the board of directors and the scientific advisory board. The HudsonAlpha Scientific Advisory Board (SAB) supports the institute’s founding mission by reviewing and advising on scientific and academic activities.
A team of uniquely skilled and internationally known investigators serves in this capacity to ensure a world-class standard. The president selects SAB members with guidance from the SAB, faculty, and members of the board of directors.
Prior to joining TPG Biotech in 2004, Geoffrey Duyk served on the board of directors and was president of research and development at Exelixis where he led a 550+ person group focused on the discovery and development of small molecule therapeutics. Prior to Exelixis, he was one of the founding scientific staff at Millennium Pharmaceuticals.
Tom Maniatis, Ph.D. Tom Maniatis is the Isidore S. Edelman Professor and chairman of the department of biochemistry and molecular biophysics at the Columbia University Medical Center. He received his B.S. and M.S. degrees from the University of Colorado at Boulder in chemistry and biology, and his Ph.D. in molecular biology from Vanderbilt University.
Dr. Sheffield received his bachelor of science degree in zoology from Brigham Young University and his M.D. and Ph.D. degrees from the University of Chicago. Dr. Sheffield completed a pediatric residency, a medical genetics fellowship and postdoctoral work at the University of California, San Francisco.
Dr. Louisa Stark is a Professor of Human Genetics and director of the Genetic Science Learning Center. Her research interests focus on science and health education for students and educators from the K-12 level through graduate and medical education as well as patients and members of the lay public.
Dr. Sharon Plon is a board-certified medical geneticist and a longstanding researcher in the areas of cancer genetics, including the discovery of new cancer susceptibility genes and early implementation of genomic testing in medicine. At Texas Children’s Hospital, she founded the Cancer Genetics Clinic in 1995 and is Director of the Texas Children’s Cancer Genetics and Genomics Program.
Dr. Barbara Wold is the Bren professor of molecular biology and director of the Beckman Institute at Caltech. She began working on genome structure and gene regulation during embryo development for her Ph.D. thesis at Caltech, and developed ways to assay cis-regulatory element function during postdoctoral work at Columbia.